Skip to main content
ABION Inc. logo

ABION Inc. — Investor Relations & Filings

Ticker · 203400 ISIN · KR7203400007 KO Professional, scientific and technical activities
Open in API
Filings indexed 409 across all filing types
Latest filing 2023-10-26 Report Publication Anno…
Country KR South Korea
Listing KO 203400

About ABION Inc.

https://abionbio.com/en/

ABION Inc. is a clinical-stage biopharmaceutical company dedicated to the discovery and development of innovative medicines, focusing on first-in-class and best-in-class therapeutics for oncology and viral diseases. The company's lead oncology asset is ABN401, a selective c-Met tyrosine kinase inhibitor (TKI) designed to treat non-small cell lung cancer (NSCLC) with MET mutations, which has shown a favorable safety profile. Another key pipeline candidate is ABN501, a novel monoclonal antibody targeting Claudin-3 for various cancers. Beyond oncology, ABION is developing ABN101, a second-generation Interferon-β formulated as a broad-spectrum anti-viral inhaler for respiratory infections. The company aims to commercialize its assets in global markets through internationally recognized clinical processes.

Recent filings

Filing Released Lang Actions
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a short announcement regarding the scheduling and logistics of an upcoming Investor Relations (IR) meeting (기업설명회). It provides the date, time, location, and purpose of the meeting, and mentions that materials will be posted on the company website and the KRX KIND system. Since it is an announcement of an event rather than the presentation materials themselves, and it is under 5,000 characters, it falls under the category of a Report Publication Announcement or general regulatory filing regarding corporate events.
2023-10-26 Korean
전환가액의조정
Capital/Financing Update Classification · 100% confidence The document is a regulatory filing from the company 'Abion' regarding the adjustment of the conversion price of convertible bonds (CB) due to a decline in market price. This type of disclosure is a standard corporate action related to capital structure and financing instruments. In the provided taxonomy, 'CAP' (Capital/Financing Update) is the most appropriate category for updates on financing activities and capital structure changes, such as convertible bond price adjustments.
2023-10-16 Korean
기타주요경영사항
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement from the company 'Abion' regarding the cancellation of a previously scheduled Extraordinary General Meeting (EGM). It does not contain full financial statements, proxy materials, or meeting minutes, but rather serves as a formal notification of a corporate event/decision. Since it does not fit into specific categories like AGM-R or PSI, and is a standard regulatory disclosure, it is classified as a general regulatory filing.
2023-10-04 Korean
[기재정정]주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a regulatory filing from the company 'Abion' regarding the cancellation of a previously announced record date for an Extraordinary General Meeting. It is a short, formal regulatory announcement (under 5,000 characters) that does not contain the full report itself but rather updates the status of a corporate action. Since it does not fit into specific categories like dividend announcements or share buybacks, it falls under the general regulatory filing category.
2023-10-04 Korean
[기재정정]주주총회소집결의
AGM Information Classification · 98% confidence The document is a regulatory filing from the company 'Abion' regarding the cancellation of a previously announced Extraordinary General Meeting (EGM). It is titled '주주총회소집결의' (Resolution for Convening a General Meeting) but specifically functions as a 'Correction Report' (정정신고) to withdraw the meeting notice. Since it relates to the procedural management of shareholder meetings and regulatory disclosure of meeting status, it falls under the category of general regulatory announcements.
2023-10-04 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a shareholder meeting (주주총회소집결의) for the company 'Abion'. It details the date, time, location, and agenda items for an Extraordinary General Meeting. This type of document is a standard proxy solicitation or notice of meeting, which falls under the category of Proxy Solicitation & Information Statement (PSI) as it provides information to shareholders regarding an upcoming meeting and the matters to be voted upon.
2023-09-18 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.